newsfilter
← Latest News
Business Wire·

Sierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration

– Submission seeks approval of momelotinib for the treatment of myelofibrosis – Sierra Oncology, Inc. (NASDAQ:SRRA), a late-stage biopharmaceutical company on a mission to deliver transformative therapies for rare cancers, today announced the com